Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Neurogenesis and Regeneration of Nervous Tissue

Neurogenesis and Regeneration of Nervous Tissue

In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...

Tumor Progression

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...

Parkinson Disease ll: Pathophysiology

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...

Nervous Tissue: Myelin

Nervous Tissue: Myelin

The myelin sheath is a multilayered lipid and protein covering that insulates the axon of a neuron, enhancing the speed of nerve impulse conduction. Axons without this sheath are referred to as unmyelinated. Two types of neuroglia, Schwann cells in the peripheral nervous system (PNS) and oligodendrocytes in the central nervous system (CNS) are responsible for producing myelin sheaths.
Schwann cells begin to form myelin sheaths around axons during fetal development. They wrap around a small...

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Psychosis: Pathophysiology of Schizophrenia and Other Psychotic Disorders

Schizophrenia is a neurodevelopmental disorder whose origins are rooted in complex genetic components. Despite our burgeoning understanding, the pathophysiology of this disorder remains incompletely deciphered.
Researchers have identified genetic factors that increase susceptibility to schizophrenia, underscoring the intricate interplay between genetics and environment in disease development. At the core of schizophrenia's pathophysiology is excessive dopaminergic neurotransmission within...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Integrated proteomic and targeted Next Generation Sequencing reveal relevant heterogeneity in lower-grade meningioma and ANXA3 as a new target in NF2 mutated meningiomas.

EBioMedicine·2025

Same author

Correction: Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.

Oncogene·2024

Same author

Targeting MERTK on tumour cells and macrophages: a potential intervention for sporadic and NF2-related meningioma and schwannoma tumours.

Oncogene·2024

Same author

Decision making for health-related research outcomes that alter diagnosis: A model from paediatric brain tumours.

Neuropathology and applied neurobiology·2024

Same author

Ribogenesis boosts controlled by HEATR1-MYC interplay promote transition into brain tumour growth.

EMBO reports·2024

Same author

miR-497 and 219 in blood aid meningioma classification.

Journal of neuro-oncology·2022

Search research articles

Related Experiment Video

Updated: May 3, 2026

Primary Culture of Human Vestibular Schwannomas

Primary Culture of Human Vestibular Schwannomas

Published on: July 20, 2014

Schwannomas and their pathogenesis.

David A Hilton¹, Clemens Oliver Hanemann

¹Department of Cellular and Anatomical Pathology, Derriford Hospital, Plymouth, UK.

Brain Pathology (Zurich, Switzerland)

|January 24, 2014

Summary

This summary is machine-generated.

Schwannomas, often linked to genetic syndromes like neurofibromatosis type 2 (NF2), arise from merlin protein dysfunction. Understanding merlin

Keywords:

Carney's complex NF2 merlin pathogenesis schwannoma schwannomatosis

More Related Videos

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

A Unified Methodological Framework for Vestibular Schwannoma Research

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

Related Experiment Videos

Last Updated: May 3, 2026

Primary Culture of Human Vestibular Schwannomas

Primary Culture of Human Vestibular Schwannomas

Published on: July 20, 2014

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

A Unified Methodological Framework for Vestibular Schwannoma Research

A Unified Methodological Framework for Vestibular Schwannoma Research

Published on: June 20, 2017

Area of Science:

Oncology
Genetics
Cell Biology

Background:

Schwannomas are typically benign (WHO grade I) tumors, rarely becoming malignant.
They can arise spontaneously or be associated with familial tumor syndromes, including neurofibromatosis type 2 (NF2), schwannomatosis, and Carney's complex.
The core of schwannoma pathogenesis involves the loss of function of the merlin protein, often due to genetic alterations in the NF2 gene.

Purpose of the Study:

To discuss the genetic pathways and morphological characteristics of schwannomas in the context of various genetic syndromes.
To review the multifaceted roles of merlin in both the nucleus and cell membrane.
To summarize current knowledge on how merlin loss contributes to schwannoma development and identify potential therapeutic targets.

Main Methods:

This is a review article, synthesizing existing research on schwannoma genetics, morphology, and pathogenesis.
It integrates information on the NF2 gene, merlin protein functions, and associated tumor syndromes.
The review focuses on analyzing the mechanisms linking merlin inactivation to tumor formation.

Main Results:

Schwannoma development is fundamentally linked to merlin (NF2 gene product) dysfunction.
Merlin plays critical roles at the cell membrane and within the nucleus, influencing cell behavior.
Different genetic syndromes present distinct pathways leading to merlin inactivation and subsequent schwannoma formation.

Conclusions:

Merlin's loss of function is central to schwannoma pathogenesis across various genetic contexts.
Understanding merlin's diverse cellular functions is key to elucidating tumor development.
Identifying the mechanisms of merlin inactivation provides avenues for novel therapeutic strategies against schwannomas.